New study to test best option for repeat AF treatment
NCT ID NCT07245147
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at two ways to treat atrial fibrillation (AF) that comes back after a first ablation. Patients who still have symptoms despite medication will be randomly assigned to either a repeat ablation or a pacemaker with AV node ablation. The goal is to see which approach improves quality of life more and to plan a larger future trial. Only 16 people will take part in this early phase.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
McGill University Health Center
Montreal, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a smartphone alert replace daily blood thinners for AF?
- Blood fat clues could flag hidden heart rhythm risk
- Can a new heart ablation technique work without x-rays?
- Which blood thinner is safer for heart patients? a Head-to-Head test
- Smartphone light sensor may spot when an irregular heartbeat fixes itself
- Can a Wrist-Worn sensor outsmart atrial fibrillation?